Drug Database · Clinicians

Lamivudine efavirenz + Tenofovir disoproxil

Brands (1) AvonzaShow all

Direct acting antiviral (combination of antivirals for treatment of HIV infection) PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • lamivudine efavirenz no separate page
  • Use: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg. US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 300 mg/300 mg/400 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Lamivudine efavirenz + Tenofovir disoproxil as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Lamivudine efavirenz + Tenofovir disoproxil
Package insert
AvonzaTenofovir disoproxil fumarate + Lamivudine Efavirenz
300mg/300mg/400mg Film-Coated TabletWhite HDPE Bottle with White Opaque PP Cap x 30's (Box of 30's); Blue HDPE Bottle with Blue Opaque PP Cap x 30's
Rx
Mylan Laboratories Limited.India
S.M.H.P. Marketing & Consultancy
DR-XY48750
May 26, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .